A prospective randomized multi-center study was undertaken for 2 years and 3 months from November 1982 , with the aim of examining the significance of using a combination of futraful ( FT ) and tamoxifen ( TAM ) for postoperative adjuvant therapy for stage II breast cancer after curative surgery .
